Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Burkitt Lymphoma 12Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Immunoglobulin Light-chain Amyloidosis 6Vomiting 5Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Nausea 5Leukemia, Myeloid, Acute 5Leukemia 5Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Lymphoma 4Hodgkin Disease 4Breast Neoplasms 4Blast Crisis 4Smoldering Multiple Myeloma 3Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Brain Neoplasms 3Sarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neuroblastoma 2Lymphoma, Follicular 2

Interventions

Tamoxifen 12Early Intervention, Educational 7Methods 6Practice Guidelines as Topic 5Neoadjuvant Therapy 5Immunohistochemistry 5Counseling 5Chemotherapy, Adjuvant 5Anastrozole 5Standard of Care 4Specimen Handling 4Radiotherapy 4Psychiatric Rehabilitation 4Mastectomy, Segmental 4Mass Spectrometry 4Letrozole 4Educational Status 4Behavior Therapy 4Gene Expression Profiling 3Biopsy 3exemestane 2Telemedicine 2Taxes 2Surveys and Questionnaires 2Soybean Proteins 2Simvastatin 2Sentinel Lymph Node Biopsy 2Radiosurgery 2Radiation Dose Hypofractionation 2Radiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Carcinoma In Situ × dexamethasone acetate × Clear all
NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡